
KTTA P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.07
Average-0.0855
Median-0.0900
Minimum-0.0900
Maximum-0.0700
-0.07
Past Month+0.01 (12.50%)
The P/E ratio for KTTA is -0.07 as of Jun 13, 2025. This represents a decrease of -66.67% compared to its 12-month average P/E ratio of -0.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Pasithea Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pasithea Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pasithea Therapeutics Corp to industry peers.
Pasithea Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Pasithea Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pasithea Therapeutics Corp to industry peers.
KTTA P/E Ratio Insights
See Pasithea Therapeutics Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in KTTA
Order type
Buy in
Order amount
Est. shares
0 shares
KTTA P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $0.93 | -0.09 |
May 1, 2025 | $1.52 | -0.12 |
Apr 1, 2025 | $1.24 | -0.10 |
Mar 3, 2025 | $1.10 | -0.07 |
Feb 3, 2025 | $2.12 | -0.14 |
Jan 2, 2025 | $2.93 | -0.19 |
KTTA End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.07 | -66.67% |
2024 | -0.21 | -65.00% |
2023 | -0.60 | -69.39% |
2022 | -1.96 | -79.98% |
2021 | -9.79 | — |
FAQs About Pasithea Therapeutics Corp (KTTA) P/E ratio
The latest P/E ratio of KTTA is -0.07, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Pasithea Therapeutics Corp’s last 12-month average P/E ratio is -0.21, compared to its current P/E ratio of -0.07. This reflects a decrease of -66.67%.
Pasithea Therapeutics Corp’s current P/E ratio of -0.07 is lower than its last 12-month average P/E of -0.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Pasithea Therapeutics Corp’s average P/E ratio over the last 3 years is -1.05. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Pasithea Therapeutics Corp’s average P/E ratio over the last 5 years is -1.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.